Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
tW2N1QK5wBHDqwaq
Listen
